Grant of options and PDMR Dealing
Summary by AI BETAClose X
23 December 2025
ANIMALCARE GROUP PLC
("Animalcare" or the "Company")
Grant of options and PDMR Dealing
Animalcare Group plc (AIM: ANCR), the international animal health business, announces that, on 22 December 2025, nil-cost options over a total of 294,222 ordinary shares with a nominal value of 20p per share ("the Options") were awarded to Executive Directors and PDMRs of Animalcare under the Company's Long Term Incentive Plan ("LTIP"). These are the only award of Options made to Executive Directors under the LTIP during the 2025 financial year.
The awards will vest on the third anniversary of award (22 December 2028) following the assessment of performance criteria based on Earnings Per Share (EPS) growth per annum and Total Shareholder Return (TSR) over the three-year financial period ending 31 December 2027. The use of EPS and TSR as performance metrics and the associated performance scale is unchanged from the most recent awards that were made in April 2024 for the three-year period ending 31 December 2026. Performance conditions for the Options are as follows:
|
3-year Earnings Per Share growth per annum |
Extent to which EPS tranche will vest |
|
Less than 3% |
0% |
|
3% |
25% |
|
10% |
100% |
|
Between 3% and 10% |
Between 25% and 100% on a straight-line basis |
|
Rank of the Company's TSR compared to the Comparator Group |
Extent to which the TSR tranche will vest |
|
Upper quartile or above |
100% |
|
Between median and upper quartile |
Pro rata between 25% and 100% on a ranking basis |
|
Median |
25% |
|
Below median |
0% |
50% of the Option award will be subject to the EPS performance condition and the remaining 50% will be subject to the TSR performance condition. Accordingly, if one of the performance conditions is met but the other is not, the Option award will only vest in part.
After the grant of the Options, the PDMRs set out below hold the following Options and ordinary shares:
|
PDMR |
Options Awarded |
Total Options |
Ordinary Shares |
|
Jennifer Winter |
219,296 |
633,044 |
100,650 |
|
Chris Brewster |
74,926 |
244,503 |
283,513 |
From the 2026 financial year and beyond we expect to make any option grants earlier in the year, usually in May following our annual Preliminary full year results announcement.
The notification in respect of the Option Awards set out in the Annex below was made subject to the requirements of Article 19 of the UK Market Abuse Regulation:
ANNEX
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||
|
a) |
Name |
Jennifer Winter |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status |
Chief Executive Officer |
|
|
b) |
Initial notification /Amendment |
Initial Notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Animalcare Group plc |
|
|
b) |
LEI |
213800A7XPQ528RMCC72 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument |
Options in respect of the Company's Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each |
|
|
b) |
Identification code |
GB0032350695 |
|
|
c) |
Nature of the transaction(s) |
Award of options |
|
|
d) |
Price(s) and volume(s) |
Volume(s): Nil cost options over 219,296 shares Price: Nil |
|
|
e) |
Aggregated information
- Aggregated volume
- Price |
N/A |
|
|
f) |
Date of the transaction |
22 December 2025 |
|
|
g) |
Place of the transaction |
Outside a trading venue |
|
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||
|
a) |
Name |
Chris Brewster |
||
|
2 |
Reason for the notification |
|||
|
a) |
Position/status |
Chief Financial Officer |
||
|
b) |
Initial notification /Amendment |
Initial Notification |
||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||
|
a) |
Name |
Animalcare Group plc |
||
|
b) |
LEI |
213800A7XPQ528RMCC72 |
||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
|
a) |
Description of the financial instrument, type of instrument |
Options in respect of the Company's Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each |
||
|
b) |
Identification code |
GB0032350695 |
||
|
c) |
Nature of the transaction(s) |
Award of options |
||
|
d) |
Price(s) and volume(s) |
Volume(s): Nil-cost options over 74,926 shares Price: Nil |
||
|
e) |
Aggregated information
- Aggregated volume
- Price |
N/A |
||
|
f) |
Date of the transaction |
22 December 2025 |
||
|
g) |
Place of the transaction |
Outside a trading venue |
||
Enquiries:
|
Animalcare Group Plc |
|
|
Jennifer Winter, Chief Executive Officer Chris Brewster, Chief Financial Officer Media/ investor relations
|
+44 (0)1904 487 687
communications@animalcaregroup.com
|
|
Stifel Nicolaus Europe Limited (Nominated Adviser & Joint Broker) |
+44 (0)20 7710 7600 |
|
Ben Maddison Francis North Jason Grossman
|
|
|
Panmure Liberum (Joint Broker) |
+44 (0)20 7886 2500 |
|
Corporate Finance Freddy Crossley/Emma Earl Corporate Banking Rupert Dearden
|
|
|
Alma Strategic Communications Caroline Forde Kinvara Verdon Rose Docherty |
+44 (0)20 3405 0205 animalcare@almastrategic.com |
About Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven European countries as well as Australia, New Zealand and the UAE and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
For more information about Animalcare, please visit www.animalcaregroup.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 14 hours ago Savannah Energy
- 15 hours ago Buccaneer Energy PLC
- 15 hours ago Savannah Energy
- 16 hours ago Carclo
- 16 hours ago Schroder Japan Growth Fund